18F-FDG PET of Common Enhancing Malignant Brain Tumors-Reference-Cited by-同舟云学术

18F-FDG PET of Common Enhancing Malignant Brain Tumors

Published:2008-06 Issue:6 Volume:190 Page:W365-W369
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Kosaka Nobuyuki,Tsuchida Tatsuro,Uematsu Hidemasa,Kimura Hirohiko,Okazawa Hidehiko,Itoh Harumi

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference17 articles.

1. Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Ucoz T. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.Am J Neuroradiol2003; 24:225-233

2. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors

3. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging

4. 18-fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma

5. Delbeke D, Meyerowitz C, Lapidus RL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.Radiology1995; 195:47-52

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing prognostication and treatment response evaluation in primary CNS lymphoma with 18F-FDG-PET/CT;Neuro-Oncology;2024-08-04

2. Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma;Nuclear Medicine and Molecular Imaging;2024-02-21

3. Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer;Indian Journal of Cancer;2024-01

4. Comparative evaluation of 11C-methionine and 18F-fluorodeoxyglucose positron emission tomography for distinguishing between primary central nervous system lymphoma and isocitrate dehydrogenase-wildtype glioblastoma;Journal of Neuro-Oncology;2023-12-31

5. 99mTc(CO)3-labeled 1-(2-Pyridyl)piperazine derivatives as radioligands for 5-HT7 receptors;Annals of Nuclear Medicine;2023-11-30